L-Type Amino Acid Transporter 1 (LAT1)-Utilizing Prodrugs Are Carrier-Selective Despite Having Low Affinity for Organic Anion Transporting Polypeptides (OATPs)
Self archived versionfinal draft
MetadataShow full item record
CitationHuttunen, Johanna. Gynther, Mikko. Vellonen, KatiSisko. Huttunen, Kristiina M. (2019). L-Type Amino Acid Transporter 1 (LAT1)-Utilizing Prodrugs Are Carrier-Selective Despite Having Low Affinity for Organic Anion Transporting Polypeptides (OATPs). International journal of pharmaceutics, 571, 118714. 10.1016/j.ijpharm.2019.118714.
L-Type amino acid transporter 1 (LAT1)–utilizing prodrugs has been designed to improve drug delivery and targeting into the brain or cancer cells, since LAT1 is highly and selectively expressed on the blood-brain barrier as well as over-expressed in several types of cancer. However, less is known about the affinity of these compounds for the secondary transport mechanisms. The aim of this study was to evaluate interactions of nine LAT1-utilizing prodrugs with organic anion transporting polypeptides (OATPs). These results showed that LAT1-utilizing prodrugs can indeed, interact with OATPs, although it was considered to be minor compared to LAT1; the Km values of these compounds for LAT1 were 1–7 µM while the ones for OATPs were 73–406 µM. Moreover, utilization of LAT1 was 2–12-times more effective (compared as intrinsic clearance) than of OATPs, whose utilization seemed to be less significant at therapeutically used concentrations. According to these results, affinity for OATPs raised from the structural features of the parent drug moiety regardless of the structure of the promoiety. In conclusion, the present study shows that it is important to evaluate secondary transport mechanisms carefully, since they may have a role in pharmacokinetics of LAT1-utilizing prodrugs if LAT1 becomes saturated or un-functional.
Subjectsaffinity intrinsic clearance (CLint) L-Type amino acid transporter 1 (LAT1) organic anion transporting polypeptides (OATPs) prodrugs targeted drug delivery transport capacity
Link to the original itemhttp://dx.doi.org/10.1016/j.ijpharm.2019.118714
Showing items related by title, author, creator and subject.
L-type amino acid transporter 1 utilizing prodrugs : how to achieve effective brain delivery and low systemic exposure of drugs Puris E; Gynther M; Huttunen J; Petsalo A; Huttunen KM (Elsevier BV, 2017)L-type amino acid transporter 1 (LAT1) is selectively expressed in the blood-brain barrier (BBB) and brain parenchyma. This transporter can facilitate brain delivery of neuroprotective agents and additionally give opportunity ...
Potential traffic levels after increasing the maximum vehicle weight in environmentally efficient transportation system: The case of Finland Palander Teijo; Kärhä Kalle (International Centre for Sustainable Development of Water, 2017)The objective of this research was to study how the maximum vehicle weight (76 t) will affect roundwood transportation in environmentally efficient transportation system. Actual traffic levels were assessed with calculations ...
Tervo J; Kokkonen P; Frank M; Herty M (Elsevier BV, 2018)The paper considers a linear Boltzmann transport equation (BTE), and its Continuous Slowing Down Approximation (CSDA). These equations are used to model the transport of particles e.g. in dose calculation of radiation ...